Evaluation of a new, rapid, simple test for the detection of influenza virus

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Hurtado, Juan Carlos ^a   Mosquera, Maria Mar ^a,b   de Lazzari, Elisa ^b   Martínez, Esteban ^a   Torner, Nuria ^c,d   Isanta, Ricard ^a   de Molina, Patricia ^a   Pumarola, Tomás ^e   Marcos, Maria Angeles ^a,b   Estape, Jordi Vila ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Influenza Virus A and B; Isothermal amplification; Rapid test; Real time PCR

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NOSE SMEAR; PROSPECTIVE STUDY; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SPAIN; THROAT CULTURE; UPPER RESPIRATORY TRACT INFECTION; VIRUS DETECTION; ADULT; CHILD; EVALUATION STUDY; GENETICS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; NOSE; NUCLEIC ACID AMPLIFICATION; PHARYNX; PROCEDURES; SENSITIVITY AND SPECIFICITY; TIME FACTOR; VIROLOGY;

ADULT; CHILD; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NOSE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHARYNX; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPAIN; TIME FACTORS;

EID: 84925259254     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0775-5     Document Type: Article

References (18)

1. Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Curr Opin Pulm Med. 2014;20:242-6.
2. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med. 1997;337:874-80.
3. Labella AM, Merel SE. Influenza. Med Clin North Am. 2013;97:621-45.
4. Centers for Disease Control. Evaluation of 11 commercially available rapid influenza diagnostic tests-United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2012;61:2008-10.
5. Centers for Disease Control. Guidance for clinicians on the use of rapid influenza diagnostic tests. [ http://www.cdc.gov/flu/pdf/professionals/diagnosis/clinician_guidance:ridt.pdf ] Accessed July 1, 2014.
6. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003-32.
7. Rothberg M, He S, Rose D. Management of influenza symptoms in healthy adults: cost-effectiveness of rapid testing and antiviral therapy. J Gen Intern Med. 2003;18(10):808-15.
8. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med. 2002;113:300-7.
9. Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, et al. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods. 2008;152:25-31.
10. Feinstein A, Cicchetti D. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43:543-9.
11. Feinstein A, Cicchetti D. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol. 1990;43:551-8.
12. Fay M. Random marginal agreement coefficients: rethinking the adjustment for chance when measuring agreement. Biostatistics. 2005;6:171-80.
13. Shively R, Beck E, Fan J, Hendrickson K, Kumar S, Kramp W, et al. Evaluation of 11 commercially available rapid influenza diagnostic tests - United states, 2011-2012. Morb Mortal Wkly Rep. 2012;61:873-6.
14. Cho C, Woo M, Kim J, Cheong S. Evaluation of five rapid diagnostic kits for influenza A/B virus. J Virol Methods. 2013;187:51-6.
15. Hassan F, Nguyen A, Formanek A, Bell JJ, Selvarangan R. Comparison of the BD Veritor system for Flu A + B with the Alere BinaxNOW influenza A&B card for detection of influenza A and B viruses in respiratory specimens from pediatric patients. J Clin Microbiol. 2014;52:906-10.
16. TM System Flu A + B, Quidel® Sofia® Influenza A + B FIA, and Alere BinaxNOW® Influenza A&B compared to real-time reverse transcription-polymerase chain reaction (RT-PCR). Diagn Microbiol Infect Dis. 2014;79:10-3.
17. Bell J, Bonner A, Cohen D, Birkhahn R, Yogev R, Triner W, et al. Multicenter clinical evaluation of the novel Alere™ i Influenza A & B nucleic acid amplification test. J Clin Virol. 2014;61:81-6.
18. Nie S, Roth R, Jeffrey S, Mikhlina A, Lu X, Tang Y, et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol. 2014;52:3339-44.